BACH1 and glioblastoma: In addition, various polygenic risk models and compound nomogram models based on BACH1 have been established to assess the prognosis, such as the RKIP pathway metastasis signature (RPMS, for TNBC), BACH1 pathway metastasis signature (BPMS, an improvement from RPMS for TNBC), and a model for glioblastomas [140, 162].